HPV DNA patterns and disease implications in the follow-up of patients treated for HPV16 high-grade carcinoma in situ

Journal of Medical Virology

Volumn 78, Issue 4, 2006, Pages 494-500

  Cricca, Monica ^a   Venturoli, Simona ^a   Morselli Labate, Antonio Maria ^a   Costa, Silvano ^b   Santini, Donatella ^b   Ambretti, Simone ^a   Musiani, Monica ^a   Zerbini, Marialuisa ^a,b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Disease implications; HPV16; Molecular parameters

Indexed keywords

VIRUS DNA;

ADULT; ARTICLE; CANCER GRADING; CLINICAL ARTICLE; COLPOSCOPY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CONIZATION; UTERINE CERVIX CYTOLOGY; UTERUS BIOPSY; VIRUS LOAD;

ADULT; CARCINOMA IN SITU; CERVICAL INTRAEPITHELIAL NEOPLASIA; CERVIX UTERI; COLPOSCOPY; CONIZATION; DNA, VIRAL; FEMALE; HUMAN PAPILLOMAVIRUS 16; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS; VIRAL LOAD;

DNA VIRUSES; HUMAN PAPILLOMAVIRUS TYPE 16;

EID: 33644767317     PISSN: 01466615     EISSN: 10969071     Source Type: Journal    
DOI: 10.1002/jmv.20567     Document Type: Article

References (25)

1. Almog B, Gamzu R, Kuperminc MJ, Levin I, Fainaru O, Niv J, Bar-Am A. 2003. Human papilloma virus testing in patient follow-up post cone biopsy due to high-grade cervical intraepithelial neoplasia. Gynecol Oncol 88:345-350.
2. Bar-Am A, Gamzu R, Levin I, Fainaru O, Niv J, Almog B. 2003. Follow-up by combined cytology and human papillomavirus testing for patients post-cone biopsy: Results of a long-term follow-up. Gynecol Oncol 91:149-153.
3. Bavin PJ, Giles JA, Deery A, Crow J, Griffiths PD, Emery VC, Walker PG. 1993. Use of semi-quantitative PCR for human papillomavirus DNA type 16 to identify women with high grade cervical disease in a population presenting with a mildly dyskaryotic smear report. Br J Cancer 67:602-605.
4. Berumen J, Unger ER, Casas L, Figueroa P. 1995. Amplification of human papillomavirus types 16 and 18 in invasive cervical cancer. Hum Pathol 26:676-681.
5. Costa S, De Simone P, Venturoli S, Cricca M, Zerbini ML, Musiani M, Terzano P, Santini D, Cristiani P, Syrjanen S, Syrjanen K. 2003. Factors predicting human papillomavirus clearance in cervical intraepithelial neoplasia lesions treated by conization. Gynecol Oncol 90:358-365.
6. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. 1992. Human papillomavirus type 16 in cervical smears as predictor of high-grade cervical intraepithelial neoplasia. Lancet 339:959-960.
7. Cuzick J, Terry G, Ho L, Hollingworth T, Anderson M. 1994. Type-specific human papillomavirus DNA in abnormal smears as a predictor of high-grade cervical intraepithelial neoplasia. Br J Cancer 69:167-171.
8. Kalantari M, Karlsen F, Kristensen G, Holm R, Hagmar B, Johansson B. 1998. Disruption of the El and E2 reading frames of HPV 16 in cervical carcinoma is associated with poor prognosis. Int J Gynecol Pathol 17:146-153.
9. Lukaszuk K, Liss J, Wozniak I, Emerich J, Wojcikowski C. 2003. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR. J Clin Microbiol 41:608-612.
10. Manos MM, Ting Y, Wright DK, Lewis AJ, Broker TR, Wolinsky SM. 1989. Use of polymerase chain reaction amplification for the detection of genital human papillomaviruses. Cancer Cells 7:209-214.
11. Milojkovic M. 2002. Residual and recurrent lesions after conization for cervical intraepithelial neoplasia grade 3. Int J Gynaecol Obstet 76:49-53.
12. Munger K, Howley PM. 2002. Human papillomavirus immortalization and transformation functions. Virus Res 89:213-228.
13. Nagai Y, Maehama T, Asato T, Kanazawa K. 2000. Persistence of human papillomavirus infection after therapeutic conization for CIN 3: Is it an alarm for disease recurrence? Gynecol Oncol 79:294-299.
14. Nobbenhuis MA, Meijer CJ, van den Brule AJ, Rozendaal L, Voorhorst FJ, Risse EK, Verheijen RH, Heimerhorst TJ. 2001. Addition of high-risk HPV testing improves the current guidelines on follow-up after treatment for cervical intraepithelial neoplasia. Br J Cancer 84:796-801.
15. Paraskevaidis E, Kalantaridou SN, Paschopoulos M, Zikopoulos K, Diakomanolis E, Dalkalitsis N, Makrydimas G, Pappa L, Malamou-Mitsi V, Agnantis NJ. 2003. Factors affecting outcome after incomplete excision of cervical intraepithelial neoplasia. Eur J Gynaecol Oncol 24:541-543.
16. Peitsaro P, Johansson B, Syrjanen S. 2002. Integrated human papillomavirus type 16 is frequently found in cervical cancer precursors as demonstrated by a novel quantitative real-time PCR technique. J Clin Microbiol 40:886-891.
17. Saiki RK, Scharf S, Faloona F, Mullis KB, Horn GT, Erlich HA, Arnheim N. 1985. Enzymatic amplification of beta-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 230:1350-1354.
18. Sarian LO, Derchain SF, Andrade LA, Tambascia J, Morais SS, Syrjanen KJ. 2004. HPV DNA test and Pap smear in detection of residual and recurrent disease following loop electrosurgical excision procedure of high-grade cervical intraepithelial neoplasia. Gynecol Oncol 94:181-186.
19. Sun XW, Ferenczy A, Johnson D, Koulos JP, Lungu O, Richart RM, Wright TC, Jr. 1995. Evaluation of the Hybrid Capture human papillomavirus deoxyribonucleic acid detection test. Am J Obstet Gynecol 173:1432-1437.
20. Sun CA, Lai HC, Chang CC, Neih S, Yu CP, Chu TY. 2001. The significance of human papillomavirus viral load in prediction of histologic severity and size of squamous intraepithelial lesions of uterine cervix. Gynecol Oncol 83:95-99.
21. Syrjänen K. 2000. Natural history of cervical HPV infections and CIN. In: Syrjänen K, Syrjänen S, editors. Papillomavirus infections in human pathology. New York: J. Wiley & Sons, pp 142-166.
22. Tonon SA, Picconi MA, Bos PD, Zinovich JB, Galuppo J, Alonio LV, Teyssie AR. 2001. Physical status of the E2 human papilloma virus 16 viral gene in cervical preneoplastic and neoplastic lesions. J Clin Virol 21:129-134.
23. Venturoli S, Cricca M, Bonvicini F, Giosa F, Pulvirenti FR, Galli C, Musiani M, Zerbini M. 2002. Human papillomavirus DNA testing by PCR-ELISA and hybrid capture II from a single cytological specimen: Concordance and correlation with cytological results. Clin Virol 25:177-185.
24. Yoshinouchi M, Hongo A, Nakamura K, Kodama J, Itoh S, Sakai H, Kudo T. 1999. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers. J Clin Microbiol 37:3514-3517.
25. Zerbini M, Venturoli S, Cricca M, Gallinella G, De Simone P, Costa S, Santini D, Musiani M. 2001. Distribution and viral load of type specific HPVs in different cervical lesions as detected by PCR-ELISA. J Clin Pathol 54:377-380.